India's Bharat Biotech submits data on COVID-19 drug trial in children

Earlier, the WHO said it will take a call on granting Emergency Use Listing (EUL) status for Bharat Biotech's COVID-19 vaccine Covaxin next week.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news